Compound Detail
CHEMBL48582
SAFINAMIDE MESYLATE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL48582 |
| Name | SAFINAMIDE MESYLATE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | YKOCHIUQOBQIAC-YDALLXLXSA-N |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL396778 |
| Active Moiety | CHEMBL396778 |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
11
Publications
10
Known Names
1
Indications
1
Mechanisms
Molecular Properties
302.4
MW (Da)
2.37
ALogP
3
HBA
2
HBD
64.3
PSA (Ų)
0.83
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2015 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Monoamine oxidase B inhibitor | INHIBITOR | Amine oxidase [flavin-containing] B | ✓ | ✓ |
Indications
Parkinson Disease
Activity Summary
IC50 3 meas. best 7.71
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sigma non-opioid intracellular receptor 1 CHEMBL3602 | IC50 | 7.71 | 7.71 | 19.7 | 1 |
| Sodium channel alpha subunits; brain (Types I, II, III) CHEMBL2095171 | IC50 | 5.09 | 5.09 | 8200.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Sigma non-opioid intracellular receptor 1 | IC50 | = | 19.7 | nM | 7.71 | Inhibition of [3H]pentazocine binding to Opioid receptor sigma 1 | 10498200 |
| Sodium channel alpha subunits; brain (Types I, II, III) | IC50 | = | 8200.0 | nM | 5.09 | Binding of [3H]batrachotoxin (BTX) to rat brain sodium channel | 10406642 |
| Sodium channel alpha subunits; brain (Types I, II, III) | IC50 | = | 8200.0 | nM | 5.09 | Inhibition of [3H]batrachotoxin binding to rat brain sodium channel | 10498200 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 10406642 | 10.1016/s0960-894x(99)00271-1 | Mus musculus | 3 |
| 10406642 | 10.1016/s0960-894x(99)00271-1 | Sodium channel alpha subunits; brain (Types I, II, III) | 2 |
| 10498200 | 10.1016/s0960-894x(99)00415-1 | Sodium channel alpha subunits; brain (Types I, II, III) | 2 |
| 10498200 | 10.1016/s0960-894x(99)00415-1 | Rattus norvegicus | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 10406642 | 10.1016/s0960-894x(99)00271-1 | ADMET | 1 |
| 10498200 | 10.1016/s0960-894x(99)00415-1 | Sigma non-opioid intracellular receptor 1 | 1 |
| 10498200 | 10.1016/s0960-894x(99)00415-1 | Unchecked | 1 |
| 22122484 | 10.1021/jm201082a | ADMET | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
Data from ChEMBL 36 via Core Engine